CMS has determined Medicare Parts A and B should cover screening for the hepatitis C virus order by primary care providers for certain adults. There is enough evidence to show screening for the virus ...
Hepatitis C is appropriately recognized as a serious liver disease with significant morbidity and mortality. Although it may manifest as an acute infection, roughly 75% of cases progress to a chronic ...
The FDA has greenlit its first point-of-care diagnostic test for hepatitis C, capable of using only a fingerstick blood sample, in a bid to quickly connect patients with antiviral drugs. “Despite the ...